High-intensity Laser Therapy and Stretching Exercises for Chronic Non-specific Neck Pain: a Feasibility Study

Effects of High-Intensity Laser Therapy and Stretching Exercises on Chronic Non-Specific Neck Pain: Findings From a Clinical Trial

Chronic non-specific neck pain (CNNP) poses a significant challenge in healthcare, sparking interest in conservative and innovative therapeutic options such as high-intensity laser therapy (HILT). While evidence of its efficacy in this specific context remains limited, there is a robust foundation supporting the use of HILT in managing chronic neck pain, demonstrating effectiveness in pain reduction and functional improvement. Therefore, the aim of this study is to evaluate the clinical response to HILT treatment in patients with CNNP, investigating its potential therapeutic benefits and adverse effects. The findings of this study will provide valuable insights into the clinical experience with HILT in this population, serving as a pivotal starting point for future research in this field.

In a clinical trial, patients with CNNP will undergo a treatment regimen consisting of two weekly sessions of HILT and stretching exercises over four weeks. The study aims to assess primary outcomes such as resting pain intensity (RPI), movement pain intensity (MPI), and pain pressure threshold (PPT), measured using the numerical pain rating scale and algometry. Secondary outcomes will include cervical range of motion (CROM) and neck disability, assessed through inclinometry and the Neck Disability Index (NDI). Evaluations will occur post-treatment, with a follow-up assessment scheduled one month later.

1.1 Study Type and Design: Experimental design for a non-controlled clinical trial.The study will be conducted in the Electrophysical Agents Laboratory (KIN 401) at the School of Physical Therapy, Faculty of Rehabilitation Sciences, Casona de las Condes Campus, Universidad Andrés Bello, located at Calle Fernández Concha Nº700, Las Condes, Santiago, Chile. The sample will be selected from the university population of the same faculty. The study group will be determined through a non-probabilistic sampling process. Participants will be recruited via a closed-ended questionnaire constructed according to selection criteria. The minimum number of participants required for the study will be calculated using the G-Power program, with a minimum of 20 participants. Subjects with CNNP pain will be recruited and will receive 8 sessions of HILT and stretching exercises over 4 weeks. Relevant outcomes will include resting pain intensity (RPI), movement pain intensity (MPI), and pressure pain threshold (PPT). Additionally, cervical range of motion (CROM) and neck disability (ND) will be assessed. Evaluations will be conducted at three time points: before treatment, at the end of treatment, and at a one-month follow-up evaluation.

1.2 Overall Objective To evaluate the effect of high-intensity laser therapy on reducing pain, increasing pain pressure threshold, improving cervical range of motion, and decreasing cervical disability in patients with non-specific chronic neck pain.

1.3 Specific Objectives - Determine the difference in cervical pain intensity before and after high-intensity laser therapy treatment.

• Assess the change in cervical pain pressure threshold before and after treatment with high-intensity laser therapy.
• Measure improvement in cervical range of motion in terms of flexion, extension, rotation, and lateral bending following high-intensity laser therapy.
• Evaluate the reduction in cervical disability using the cervical disability index before and after treatment with high-intensity laser therapy.
• Investigate the correlation between pain reduction, pain pressure threshold, improvement in range of motion, and reduction in cervical disability in response to high-intensity laser therapy.

1.4 Phases of the clinical trial

• Study Preparation and Design: In this initial stage, the experimental design of the non-controlled clinical trial will be established, defining study objectives and selecting key variables for measurement. Additionally, the laboratory environment will be prepared, and the research protocol will be designed.
• Treatment Implementation and Execution: During this phase, the study will be implemented, involving sample selection through a non-probabilistic sampling process, administration of the treatment (HILT and stretching exercises) to recruited participants, and collection of relevant clinical data.
• Evaluation and Results Analysis: The final stage will focus on evaluating the obtained results, including measurement of variables such as pain intensity, pain pressure threshold, cervical range of motion, and cervical disability. Statistical analyses will be conducted to determine treatment efficacy, and conclusions will be drawn based on the study findings.

2.1 Conceptual Definition of Variables:

- Pain intensity at rest: discomfort or more intense forms of pain localized in the cervical region, lateral neck, shoulders, or scapular region, reported by participants while at rest.

• Pain intensity at movement: discomfort or more intense forms of pain localized in the cervical region, lateral neck, shoulders, or scapular region, manifested by participants during neck movements.
• Pain pressure threshold: the minimum amount of pressure applied to a specific area of the body that induces the sensation of pain.
• Cervical range of motion: capacity of movement in the cervical spine, including movements in various anatomical planes such as flexion, extension, lateral bending, and rotation.
• Neck disability: limitation or restriction in neck functional capacity, manifested as difficulty in performing daily activities such as neck movement, maintaining an upright posture, performing work tasks, or engaging in recreational activities.
• Stretching exercises: static passive stretching exercises performed bilaterally by the therapist on the upper trapezius, levator scapulae, and scalene muscles, each held for 30 seconds with 30-second intervals, totaling 3 sets for each muscle group.
• High-intensity laser therapy uses concentrated laser light with power greater than 0.5 watts to treat musculoskeletal injuries, chronic pain, and promote healing through thermal effects and photobiomodulation.

2.2 Operational Definition of Variables: - Pain intensity at rest: assessed using the Numeric Pain Rating Scale (NPRS) from Gymna (R). measured on a scale from 0 to 10, where 0 represents no pain and 10 represents the most pain the participant reported.

- Pain intensity at movement: assessed using the Numeric Pain Rating Scale (NPRS) from Gymna (R). measured on a scale from 0 to 10, where 0 represents no pain and 10 represents the most pain the participant reported.

- Pain pressure threshold: assessed using pressure algometry with the FPX Wagner pressure algometer (R). The pressure threshold will be measured in pounds per square centimeter (lb/cm2).

- Cervical range of motion: assessed using inclinometry with the CROM device. The range of motion will be quantified in degrees (°).

- Neck disability is assessed using the Neck Disability Index (NDI). Cervical disability will be expressed as a percentage, where 0% indicates no disability and 100% indicates maximum disability.

• Stretching exercises: static and passive stretching exercises performed bilaterally by the therapist on the upper trapezius, levator scapulae, and scalene muscles. Each exercise will be held for 30 seconds with 30-second intervals, and 3 sets will be performed for each muscle group.
• High-intensity laser: application of a high-power laser using the BTL-6000 device at 12 Watts.

2.3 Types of Variables:

- Pain intensity at rest: dependent variable, ordinal qualitative.

• Pain intensity at movement: dependent variable, ordinal qualitative.

• Pain pressure threshold: dependent variable, continuous quantitative.

• Cervical range of motion: dependent variable, continuous quantitative.

• Neck disability: dependent variable, continuous quantitative.

• Cervical stretching exercises: independent variable, nominal qualitative.

• High-intensity laser therapy: independent variable, continuous quantitative.

  3. Ethical Considerations: The study received approval from the Ethics Committee of the Metropolitan East Health Service of Santiago, Chile, on October 26, 2022, in accordance with the principles of the Declaration of Helsinki (approval number 20200234).

  4. Participants: Participants will be recruited from the community of Universidad Andrés Bello. The study will be advertised through official channels, including email distribution and publication on the institutional website. Additionally, communication channels such as emails, social media, and panels within the Physical Therapy Department will be utilized. Volunteers will be contacted via telephone or email to attend the Electrophysical Agents Laboratory at the Faculty of Rehabilitation Sciences.

  5. Sample size: The sample size will be determined using G-Power software, considering a power of 90% (1-β), a confidence level of 95%, a significance level of 5% (α), and an effect size of 0.6. Previous studies in individuals with CNP have shown differences in pain intensity, favoring HILT plus exercise over ultrasound plus exercise. Therefore, a minimum sample size of 17 participants will be established. To accommodate potential dropouts during the study or follow-up, an additional 15% will be added to the sample, resulting in a total of at least 20 participants.

  6. Intervention: Participants will form a study group receiving HILT as an intervention. Alongside laser therapy, they will undergo a regimen of passive bilateral static stretching exercises targeting the upper trapezius, levator scapulae, and scalene muscles, with each stretch held for 30 seconds per set. These stretching exercises will be conducted immediately following the HILT treatment. The interventions will take place twice weekly over a span of four weeks, totaling eight sessions. These interventions will occur twice a week for four weeks, totaling eight sessions. Each treatment will be administered by an independent therapist ensuring intervention blindness.

• High-intensity laser therapy. For laser therapy, the BTL-6000 device with 12W power and a wavelength of 1,064 nm will be used. The treatment protocol integrates manual scanning and point techniques following De la Barra et al. It consists of three phases: Phase 1, manual scanning with 12 W power for 42 seconds per upper trapezius muscle, delivering 1,000 J in total; Phase 2, point technique (static) using 4 W power for 10 seconds per point, delivering 120 J in total; Phase 3, manual scanning with 6 W power for 83 seconds per upper trapezius muscle, delivering 1,000 J in total.

• Stretching exercise. Participants will also undergo passive bilateral static stretching exercises targeting the upper trapezius, levator scapulae, and scalene muscles. A therapist will administer these exercises, lasting 30 seconds each with a 30-second rest between sets, following the HILT treatment.

  7. Outcomes of Interest: The primary outcome measures will include resting pain intensity (RPI), pain intensity during movement (MPI), both assessed using the Numerical Pain Rating Scale (NPRS), and pain pressure threshold (PPT), evaluated with algometry. Algometry will assess six bilateral points across the cervical region, shoulders, and interscapular region. Secondary outcomes will encompass cervical range of motion (CROM), evaluated using inclinometry, and cervical disability, assessed with the Neck Disability Index (NDI). Evaluations will occur at three time points: baseline (before treatment), immediately post-treatment, and four weeks post-treatment (follow-up assessment). Two independent evaluators will conduct the assessments to ensure blindness in the evaluation process: one will handle the algometry assessment and NPRS application, while the other will handle the CROM evaluation. Neck disability will be assessed using the self-administered NDI questionnaire.

  8. Statistical Analysis: Descriptive statistics such as means, standard deviations, medians, and interquartile ranges will be used to analyze the variables RPI, MPI, PPT, CROM, and ND, based on data distribution. Tables will be created with demographic data such as gender and body mass index. For inferential analysis, tests for normality and homoscedasticity, such as the Shapiro-Wilk test and Bartlett's test, respectively, will be employed. Depending on the results, parametric or non-parametric tests will be selected: a one-way ANOVA or Kruskal-Wallis test to evaluate differences between sessions. Post-hoc analyses will be conducted using Tukey's or Bonferroni's tests for multiple comparisons. The significance level will be set at 0.05, and data analysis will be performed using IBM Statistical Package for the Social Sciences (SPSS) software (version 26; SPSS Inc.; Chicago, IL).

Inclusion Criteria:

• Age 18 or older
• Both sexes
• Experiencing chronic neck pain: Defined as pain or discomfort in the cervical region between the upper nuchal line and the T1 spinous process or the shoulder girdle. Lasting at least three months
• Neck Disability Index (NDI) score of 5 or higher
• Pain intensity of at least three on the Numerical Pain Rating Scale (NPRS) at rest

Exclusion Criteria:

• Any musculoskeletal injuries sustained in the neck or shoulders within the past three months
• The presence of osteosynthesis materials in the vicinity of the shoulders, neck, or surrounding areas
• The existence of skin wounds or changes, such as psoriasis, scars, or burns, in the neck or shoulder region.
• Continuous usage of analgesic medication, anti-inflammatories, or muscle relaxants.
• Neurological disorders, which include paresthesias, partial or total loss of sensation, decreased strength, and color changes in the neck, arms, forearms, or hands.
• Diagnosis of photosensitivity
• Skin types V and VI, as determined by the Fitzpatrick scale
• Solar urticaria or adverse reactions to sunlight are present.
• Diagnosis of autoimmune diseases (e.g., dermatomyositis, systemic lupus erythematosus, hepatic porphyria, carcinoid syndrome, pellagra)
• Diagnosis of cancer or tumors within the past five years
• Epilepsy